BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 21707928)

  • 1. A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.
    Montorsi F; Aversa A; Moncada I; Perimenis P; Porst H; Barker C; Shane MA; Sorsaburu S
    J Sex Med; 2011 Sep; 8(9):2617-24. PubMed ID: 21707928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tadalafil once daily in men with erectile dysfunction: an integrated analysis of data obtained from 1913 patients from six randomized, double-blind, placebo-controlled, clinical studies.
    Porst H; Gacci M; Büttner H; Henneges C; Boess F
    Eur Urol; 2014 Feb; 65(2):455-64. PubMed ID: 24119319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT).
    Montorsi F; Brock G; Stolzenburg JU; Mulhall J; Moncada I; Patel HR; Chevallier D; Krajka K; Henneges C; Dickson R; Büttner H
    Eur Urol; 2014 Mar; 65(3):587-96. PubMed ID: 24169081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
    Porst H; Giuliano F; Glina S; Ralph D; Casabé AR; Elion-Mboussa A; Shen W; Whitaker JS
    Eur Urol; 2006 Aug; 50(2):351-9. PubMed ID: 16766116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of tadalafil in a Western European population of men with erectile dysfunction.
    Eardley I; Gentile V; Austoni E; Hackett G; Lembo D; Wang C; Beardsworth A
    BJU Int; 2004 Oct; 94(6):871-7. PubMed ID: 15476525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
    Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
    Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A return to normal erectile function with tadalafil once daily after an incomplete response to as-needed PDE5 inhibitor therapy.
    Kim ED; Seftel AD; Goldfischer ER; Ni X; Burns PR
    J Sex Med; 2014 Mar; 11(3):820-30. PubMed ID: 23841532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tadalafil 2.5 or 5 mg administered once daily for 12 weeks in men with both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia: results of a randomized, placebo-controlled, double-blind study.
    Egerdie RB; Auerbach S; Roehrborn CG; Costa P; Garza MS; Esler AL; Wong DG; Secrest RJ
    J Sex Med; 2012 Jan; 9(1):271-81. PubMed ID: 21981682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tadalafil in the treatment of Latin American men with erectile dysfunction: results of integrated analyses.
    Rubio-Aurioles E; Casabé A; Torres LO; Quinzaños L; Glina S; Filimon I; Kopernicky V; Leñero E
    J Sex Med; 2008 Aug; 5(8):1965-76. PubMed ID: 18466266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of once-daily tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline.
    Shabsigh R; Seftel AD; Kim ED; Ni X; Burns PR
    J Sex Med; 2013 Mar; 10(3):844-56. PubMed ID: 23035781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.
    Broderick GA; Donatucci CF; Hatzichristou D; Torres LO; Valiquette L; Zhao Y; Loughney K; Sides GD; Ahuja S
    J Sex Med; 2006 Jul; 3(4):668-675. PubMed ID: 16839323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction.
    Skoumal R; Chen J; Kula K; Breza J; Calomfirescu N; Basson BR; Kopernicky V
    Eur Urol; 2004 Sep; 46(3):362-9; discussion 369. PubMed ID: 15306109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability of response following cessation of tadalafil taken once daily as treatment for erectile dysfunction.
    Porst H; Glina S; Ralph D; Zeigler H; Wong DG; Woodward B
    J Sex Med; 2010 Oct; 7(10):3487-94. PubMed ID: 20584129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of once-daily tadalafil on treatment satisfaction, psychosocial outcomes, spontaneous erections, and measures of endothelial function in men with erectile dysfunction but naive to phosphodiesterase type 5 inhibitors.
    Porst H; Brock GB; Kula K; Moncada I; Montorsi F; Basson BR; Kinchen K; Aversa A
    J Androl; 2012; 33(6):1305-22. PubMed ID: 22790642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with diabetes mellitus and erectile dysfunction: Scheduled use vs. on-demand regimen evaluation (SURE) study in 14 European countries.
    Buvat J; van Ahlen H; Schmitt H; Chan M; Kuepfer C; Varanese L
    J Sex Med; 2006 May; 3(3):512-20. PubMed ID: 16681477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of oral tadalafil in the treatment of men in Canada with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical trial.
    Carrier S; Brock GB; Pommerville PJ; Shin J; Anglin G; Whitaker S; Beasley CM
    J Sex Med; 2005 Sep; 2(5):685-98. PubMed ID: 16422827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of on-demand oral tadalafil in the treatment of men with erectile dysfunction in Taiwan: a randomized, double-blind, parallel, placebo-controlled clinical study.
    Chen KK; Jiann BP; Lin JS; Lee SS; Huang ST; Wang CJ; Ju-Ton H; Su CK; Costigan TM; Emmick JT
    J Sex Med; 2004 Sep; 1(2):201-8. PubMed ID: 16422975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
    Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
    J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin-controlled, 12-week double-blind study.
    Giuliano F; Oelke M; Jungwirth A; Hatzimouratidis K; Watts S; Cox D; Viktrup L
    J Sex Med; 2013 Mar; 10(3):857-65. PubMed ID: 23346990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the efficacy and tolerability of tadalafil 10 mg and 20 mg in Japanese patients with severe erectile dysfunction.
    Marumo K; Imaoka T; Fujimoto K; Watts S; Stothard D; McGill J
    J Sex Med; 2007 May; 4(3):745-752. PubMed ID: 17087800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.